Showing results (1381-1390 of 2,232) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Isolation of scFvs to in vitro produced extracellular domains of EGFR family membersEva Horak, Tara Heitner, Matthew K Robinson, et al.Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibodySui Shen, Gerald L DeNardo, Aina Yuan, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Improving the tumor uptake of 99mTc-labeled neuropeptides using stabilized peptide analoguesPeter Bläuenstein, Elisa García Garayoa, Dominique Rüegg, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Intraobserver, interobserver, and day-to-day reproducibility of quantitative 99mTc-HYNIC annexin-V imaging in head and neck carcinomaHubert Vermeersch, Hamphrey Ham, Sylvie Rottey, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Gastrin-releasing peptide (GRP) analogues for cancer imagingAlexandra Varvarigou, Penelope Bouziotis, Christos Zikos, et al.Cancer Biotherapy & Radiopharmaceuticals|August 3, 2004
A theoretical radiobiological assessment of the influence of radionuclide half-life on tumor response in targeted radiotherapy when a constant kidney toxicity is maintainedWassim Abou-Jaoudé, Roger DaleCancer Biotherapy & Radiopharmaceuticals|August 3, 2004
Repeated cycles with 72-hour continuous infusion interleukin-2 in kidney cancer and melanomaWalter Quan, Wendy Brick, Mikhail Vinogradov, et al.Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibodyDaniel A Vallera, Michael Elson, Martin W Brechbiel, et al.Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
In vitro and in vivo evaluation of a 64Cu-labeled polyethylene glycol-bombesin conjugateBuck E Rogers, Debbie Della Manna, Ahmad SafavyCancer Biotherapy & Radiopharmaceuticals|April 8, 2004
99mTc-N4-[Tyr3]Octreotate Versus 99mTc-EDDA/HYNIC-[Tyr3]Octreotide: an intrapatient comparison of two novel Technetium-99m labeled tracers for somatostatin receptor scintigraphyMichael Gabriel, Clemens Decristoforo, Theodosia Maina, et al.Pageof 224